All In Biotech

Drug Trial Radar · NCT00361998

Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated Cystitis

Nitrofurantoin Macrocrystals 3 Days Vs. 7 Days in the Treatment of Women With Uncomplicated Cystitis

Last checked: Nov 19, 2026Latest source record: Mar 2, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

WithdrawnPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Withdrawn

Enrollment

400

Actual

Start

Sep 2006

Primary completion

Not stated

Study completion Jan 2007

Sponsor

Lead sponsor
HaEmek Medical Center, IsraelAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Clalit Health Services
First posted
Aug 9, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Our guidelines in the community recommend the use of NM for the treatment of women with community acquired UTI. While the length of treatment for uncomplicated cystitis with quinolones or TMP-SMX is three days, NM is recommended for seven days. However, there are not sufficient papers that establish the optimal length of treatment with NM in this population. The aim of this proposal is to evaluate and compare NM 3 day vs. 7 day treatment for the treatment of women with uncomplicated UTI.

Conditions

  • Cystitis

Interventions

  • NITROFURANTOIN MACROCRYSTALSDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Microbiological efficacy

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Research Unit, Clalit Health Services, Haifa and Western Galillee District

    Haifa, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.